Evidence map›Paper›PMID 11214178›Full record

ArticleRNA (New York, N.Y.)2001

A ribozyme selected from variants of U6 snRNA promotes 2',5'-branch formation.

T Tuschl, P A Sharp, D P Bartel

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Model systems: how chemical biologists study RNA.Current opinion in chemical biology · 2009
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

T TuschlDepartment of Biology, Massachusetts Institute of Technology, Cambridge 02139, USA.
P A Sharp
D P Bartel
Massachusetts Institute of Technology · USCenter for Cancer Research · US

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Michael Birnbaum · 1985 to 2026
$93.9M
REGULATION OF MRNA PROCESSINGR37GM034277 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SHARP, PHILLIP A · 1995 to 2004
$2.1M
MECHANISM OF ACTIVITIES OF TAT AND REV OF HIV1R01AI032486 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI SHARP, PHILLIP A · 1992 to 2001
$679k
NCI NIH HHS P30-CA14051NIAID NIH HHS R01-AI32486NIGMS NIH HHS R37-GM34277
6 · The paper itself

Abstract

In vitro selection was used to sample SnRNA-related sequences for ribozyme activities, and several 2',5'-branch-forming ribozymes were isolated. One such ribozyme is highly dependent upon an 11-nt motif that contains a conserved U6 snRNA sequence (ACAGAGA-box) known to be important for pre-mRNA splicing. The ribozyme reaction is similar to the first step of splicing in that an internal 2'-hydroxyl of an unpaired adenosine attacks at the 5'-phosphate of a guanosine. It differs in that the leaving group is diphosphate rather than a 5' exon. The finding that lariat formation can be accomplished by a small RNA with sequences related to U6 snRNA indicates that the RNA available in the spliceosome may be involved in RNA-catalyzed branch formation.

Indexed as

Genetic VariationAnimalsBase SequenceConserved SequenceExonsGene LibraryIntronsKineticsMolecular Sequence DataNucleic Acid ConformationOligodeoxyribonucleotidesPhylogenyRNA, CatalyticRNA PrecursorsRNA, Small NuclearRNA SplicingOligodeoxyribonucleotidesRNA, CatalyticRNA PrecursorsRNA, Small NuclearU6 small nuclear RNA

Identifiers

PMID11214178
PMCPMC1370066
OpenAlexW2035612101

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.